Insider Transactions in Q4 2022 at Cumberland Pharmaceuticals Inc (CPIX)
Insider Transaction List (Q4 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 11
2022
|
Joseph C Galante |
BUY
Open market or private purchase
|
Direct |
65
+0.12%
|
$130
$2.48 P/Share
|
Oct 11
2022
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
31
+0.13%
|
$62
$2.48 P/Share
|
Oct 11
2022
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
20
+0.11%
|
$40
$2.48 P/Share
|
Oct 10
2022
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
105
+0.05%
|
$210
$2.53 P/Share
|
Oct 10
2022
|
Joseph C Galante |
BUY
Open market or private purchase
|
Direct |
65
+0.12%
|
$130
$2.53 P/Share
|
Oct 10
2022
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
31
+0.13%
|
$62
$2.53 P/Share
|
Oct 10
2022
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
20
+0.11%
|
$40
$2.53 P/Share
|
Oct 07
2022
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
105
+0.05%
|
$210
$2.66 P/Share
|
Oct 07
2022
|
Joseph C Galante |
BUY
Open market or private purchase
|
Direct |
65
+0.12%
|
$130
$2.66 P/Share
|
Oct 07
2022
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
31
+0.13%
|
$62
$2.66 P/Share
|
Oct 07
2022
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
20
+0.11%
|
$40
$2.66 P/Share
|
Oct 06
2022
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
105
+0.05%
|
$210
$2.65 P/Share
|
Oct 06
2022
|
Joseph C Galante |
BUY
Open market or private purchase
|
Direct |
65
+0.12%
|
$130
$2.65 P/Share
|
Oct 06
2022
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
31
+0.13%
|
$62
$2.65 P/Share
|
Oct 06
2022
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
20
+0.11%
|
$40
$2.65 P/Share
|
Oct 05
2022
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
105
+0.05%
|
$210
$2.58 P/Share
|
Oct 05
2022
|
Joseph C Galante |
BUY
Open market or private purchase
|
Direct |
65
+0.12%
|
$130
$2.58 P/Share
|
Oct 05
2022
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
31
+0.13%
|
$62
$2.58 P/Share
|
Oct 05
2022
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
20
+0.11%
|
$40
$2.58 P/Share
|
Oct 04
2022
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
105
+0.05%
|
$210
$2.61 P/Share
|
Oct 04
2022
|
Joseph C Galante |
BUY
Open market or private purchase
|
Direct |
65
+0.12%
|
$130
$2.61 P/Share
|
Oct 04
2022
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
31
+0.13%
|
$62
$2.61 P/Share
|
Oct 04
2022
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
20
+0.11%
|
$40
$2.61 P/Share
|
Oct 03
2022
|
Kenneth Krogulski Director |
BUY
Open market or private purchase
|
Direct |
105
+0.05%
|
$210
$2.54 P/Share
|
Oct 03
2022
|
Joseph C Galante |
BUY
Open market or private purchase
|
Direct |
65
+0.12%
|
$130
$2.54 P/Share
|
Oct 03
2022
|
James Jones Director |
BUY
Open market or private purchase
|
Direct |
31
+0.13%
|
$62
$2.54 P/Share
|
Oct 03
2022
|
Caroline Young Director |
BUY
Open market or private purchase
|
Direct |
20
+0.11%
|
$40
$2.54 P/Share
|